DK0889735T3 - Immunogene metoder til behandling af gastrointestinal cancer - Google Patents

Immunogene metoder til behandling af gastrointestinal cancer

Info

Publication number
DK0889735T3
DK0889735T3 DK97905858.3T DK97905858T DK0889735T3 DK 0889735 T3 DK0889735 T3 DK 0889735T3 DK 97905858 T DK97905858 T DK 97905858T DK 0889735 T3 DK0889735 T3 DK 0889735T3
Authority
DK
Denmark
Prior art keywords
treatment
gastrointestinal cancer
gastrin
immunogenic methods
immunogenic
Prior art date
Application number
DK97905858.3T
Other languages
English (en)
Inventor
Philip C Gevas
Stephen L Karr
Stephen Grimes
Dov Michaeli
Susan A Watson
Original Assignee
Cancer Advances Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Advances Inc filed Critical Cancer Advances Inc
Application granted granted Critical
Publication of DK0889735T3 publication Critical patent/DK0889735T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97905858.3T 1996-02-08 1997-02-07 Immunogene metoder til behandling af gastrointestinal cancer DK0889735T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1141196P 1996-02-08 1996-02-08
PCT/US1997/002029 WO1997028821A1 (en) 1996-02-08 1997-02-07 Immunological methods for the treatment of gastrointestinal cancer

Publications (1)

Publication Number Publication Date
DK0889735T3 true DK0889735T3 (da) 2011-08-08

Family

ID=21750270

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97905858.3T DK0889735T3 (da) 1996-02-08 1997-02-07 Immunogene metoder til behandling af gastrointestinal cancer

Country Status (9)

Country Link
US (1) US20050025770A1 (da)
EP (1) EP0889735B1 (da)
JP (3) JP2000504692A (da)
AT (1) ATE505202T1 (da)
DE (1) DE69740173D1 (da)
DK (1) DK0889735T3 (da)
ES (1) ES2361474T3 (da)
PT (1) PT889735E (da)
WO (1) WO1997028821A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0889735T3 (da) * 1996-02-08 2011-08-08 Cancer Advances Inc Immunogene metoder til behandling af gastrointestinal cancer
US6548066B1 (en) * 1997-05-12 2003-04-15 Aphton Corporation Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
EP1839673A3 (en) * 1998-05-15 2007-11-07 Receptor Biologix, Inc. Prevention and treatment of hypergastrinemia
JP2002515458A (ja) * 1998-05-15 2002-05-28 アフトン・コーポレーシヨン 高ガストリン血症の予防および処置
CA2441228A1 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
JP2004536835A (ja) * 2001-07-09 2004-12-09 アフトン コーポレーション 肝臓、肺および食道の癌性ならびに前癌性状態の治療および防止
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
US7235376B2 (en) * 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
US20060020119A1 (en) * 2004-03-29 2006-01-26 Stephen Grimes Monoclonal antibodies to gastrin hormone
EP2567974A3 (en) 2004-09-22 2013-05-22 Cancer Advances, Inc., Monoclonal antibodies to progastrin
JP5558660B2 (ja) 2007-05-11 2014-07-23 日東電工株式会社 両面接着性感圧接着シート
CN101797382B (zh) 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
US8674064B2 (en) * 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
PT2999485T (pt) * 2013-05-21 2018-04-30 Tyg Oncology Ltd Composição imunogénica do peptido gastrina
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US140962A (en) * 1873-07-15 Improvement in feeding paper to printing-presses
US58040A (en) * 1866-09-18 Improvement in making bolts
US91574A (en) * 1869-06-22 Improvement in water-closet valves
US21786A (en) * 1858-10-12 Improvement in the manufacture of sugar
US39911A (en) * 1863-09-15 Improvement in corset skirt-supporters
US86941A (en) * 1869-02-16 Improvement in corn-planter
US1842A (en) * 1840-10-31 Machine fob cutting corks
US68326A (en) * 1867-08-27 Alcibiades j
US95028A (en) * 1869-09-21 Improved process for preserving eggs
US20119A (en) * 1858-04-27 Improvement in raking and delivering attachments to harvesters
US187152A (en) * 1877-02-06 Improvement in clothes-wringers
US69966A (en) * 1867-10-22 Joseph chadwick
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
IT1179894B (it) * 1984-12-27 1987-09-16 Rotta Research Lab Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
DK0380230T3 (da) * 1989-01-24 1995-01-16 Aphton Corp Immunogene sammensætninger mod gastrin-peptider
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
US5023077A (en) 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
US5319073A (en) * 1992-02-07 1994-06-07 The United States Of America, As Represented By The Department Of Health & Human Services Method of purifying cholecystokinin receptor protein
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5468494A (en) 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
US6359114B1 (en) * 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
DK0889735T3 (da) * 1996-02-08 2011-08-08 Cancer Advances Inc Immunogene metoder til behandling af gastrointestinal cancer
US6548066B1 (en) * 1997-05-12 2003-04-15 Aphton Corporation Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
EP1154782A4 (en) * 1999-02-24 2002-09-25 Uab Research Foundation TAXAN DERIVATIVES FOR TARGETED CANCER THERAPY

Also Published As

Publication number Publication date
WO1997028821A1 (en) 1997-08-14
JP2012097062A (ja) 2012-05-24
JP5200269B2 (ja) 2013-06-05
JP5200251B2 (ja) 2013-06-05
ES2361474T3 (es) 2011-06-17
PT889735E (pt) 2011-07-19
JP2000504692A (ja) 2000-04-18
US20050025770A1 (en) 2005-02-03
ATE505202T1 (de) 2011-04-15
DE69740173D1 (de) 2011-05-26
JP2007126461A (ja) 2007-05-24
EP0889735B1 (en) 2011-04-13
EP0889735A1 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
PT889735E (pt) Métodos imunológicos para o tratamento do cancro gastrointestinal
WO1997028821B1 (en) Immunological methods for the treatment of gastrointestinal cancer
NO983999D0 (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
IL139700A (en) Immunotherapeutic composition for the treatment of prostate cancer
BR9811264A (pt) Composições imunogênicas ao receptor de gastrina/cck-b e métodos para o tratamento de tumores
ATE512224T1 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
DK442688A (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
GR3030141T3 (en) Diphtheria toxin receptor-binding region.
IL165398A0 (en) Method for identifying immunoreactive peptides
DE69737218D1 (de) Adjuvant für transkutane Immunisation
BR9912177A (pt) Epìtopos de célula auxiliar t artificiais como imunoestimuladores para imunógenos de peptìdeo sintéticos
PT1171465E (pt) Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
EP0380230A3 (en) Immunogenic compositions against gastrin peptides
IL126803A0 (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
PL338449A1 (en) Ligands, including antibodies, exhibiting reactivity in respect to endocrine secretion cells
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
WO1991010735A3 (fr) Recepteur humain de la tsh. sequence codant pour ce recepteur
DE69626642T2 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
NZ301334A (en) Helicobacter pylori antigen
UA22181A (uk) Спосіб лікуваhhя гіпогалактії
UA30230A (uk) Спосіб лікування раку тіла матки ііі стадії